Cornerstone Capital Management Holdings LLC. Buys 16,275 Shares of Cooper Companies Inc (COO)

Cornerstone Capital Management Holdings LLC. increased its stake in Cooper Companies Inc (NYSE:COO) by 34.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 63,683 shares of the medical device company’s stock after purchasing an additional 16,275 shares during the period. Cornerstone Capital Management Holdings LLC. owned 0.13% of Cooper Companies worth $15,098,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in COO. Janus Henderson Group PLC lifted its holdings in shares of Cooper Companies by 558.5% in the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock worth $520,937,000 after purchasing an additional 1,845,368 shares during the last quarter. Koch Industries Inc. bought a new stake in shares of Cooper Companies in the 2nd quarter worth approximately $312,000. Voya Investment Management LLC lifted its holdings in shares of Cooper Companies by 973.4% in the 2nd quarter. Voya Investment Management LLC now owns 329,015 shares of the medical device company’s stock worth $78,773,000 after purchasing an additional 298,363 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. bought a new stake in shares of Cooper Companies in the 2nd quarter worth approximately $71,050,000. Finally, William Blair Investment Management LLC bought a new stake in Cooper Companies during the 2nd quarter valued at $65,037,000. 96.79% of the stock is currently owned by institutional investors and hedge funds.

In other news, Director Gary S. Petersmeyer sold 3,977 shares of Cooper Companies stock in a transaction on Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 1.60% of the stock is currently owned by company insiders.

Several brokerages have weighed in on COO. Jefferies Group reaffirmed a “buy” rating and set a $250.00 target price on shares of Cooper Companies in a research note on Tuesday, September 12th. Stephens reaffirmed an “equal weight” rating and set a $250.00 target price (up previously from $235.00) on shares of Cooper Companies in a research note on Tuesday, September 12th. Zacks Investment Research raised Cooper Companies from a “hold” rating to a “buy” rating and set a $265.00 target price on the stock in a research note on Tuesday, October 10th. KeyCorp reaffirmed a “hold” rating on shares of Cooper Companies in a research note on Monday, August 28th. Finally, Piper Jaffray Companies lifted their target price on Cooper Companies from $265.00 to $280.00 and gave the company an “overweight” rating in a research note on Friday, September 1st. Six analysts have rated the stock with a hold rating and nine have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $259.70.

Shares of Cooper Companies Inc (NYSE COO) opened at $226.56 on Monday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. The firm has a market capitalization of $11,089.94, a price-to-earnings ratio of 23.31, a price-to-earnings-growth ratio of 1.83 and a beta of 0.54. Cooper Companies Inc has a 12 month low of $168.00 and a 12 month high of $256.39.

Cooper Companies (NYSE:COO) last issued its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.64 by $0.01. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The company had revenue of $561.50 million for the quarter, compared to analysts’ expectations of $558.86 million. During the same period last year, the firm earned $2.28 EPS. The firm’s revenue for the quarter was up 8.3% on a year-over-year basis. equities research analysts expect that Cooper Companies Inc will post 11.54 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this story on another website, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this story can be viewed at https://www.com-unik.info/2017/12/11/cornerstone-capital-management-holdings-llc-buys-16275-shares-of-cooper-companies-inc-coo.html.

About Cooper Companies

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit